NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

乾眼症全球市場分析:通過推出創新療法補充市場增長

Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth

出版商 Persistence Market Research 商品編碼 1004428
出版日期 內容資訊 英文 314 Pages
商品交期: 2-3個工作天內
價格
乾眼症全球市場分析:通過推出創新療法補充市場增長 Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth
出版日期: 2021年03月04日內容資訊: 英文 314 Pages
簡介

本報告分析了乾眼症治療藥物的全球市場,並提供了疾病和產品、市場結構、主要市場推動/制約因素、市場規模/份額趨勢和預測(2020年-2030年)的概述。 ,我們正在按產品類型/處方/銷售渠道和地區/主要國家、當前市場競爭狀況、主要公司概況等調查詳細趨勢。

目錄

第 1 章執行摘要

第 2 章市場概覽

第三章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章主要成功因素

  • 乾眼症的流行病學:按國家/地區
    • 乾眼症的患病率
    • 潛在乾眼症患者人數
    • 按嚴重程度劃分的患者百分比:輕度、中度、重度
    • 接受治療的患者人數
    • MGD 患者瞼板腺功能障礙 (MGD) 的患病率和乾眼症的發生率
  • 監管場景
  • 推出新產品
  • 兌換場景
  • 乾眼症-診斷協議/標準:按主要國家
  • 乾眼症- "患者治療之旅"

第五章市場背景

  • 宏觀經濟因素
    • 全球 GDP 增長展望
    • 全球醫療行業的未來展望
  • 預測因素:相關性和影響
    • 老年人口增加
    • 乾眼症患病率增加
    • 缺乏對乾眼症的瞭解
  • 市場動態
    • 促進因素
    • 抑製器
    • 趨勢
    • 市場機會分析

第 6 章冠狀病毒傳染病 (COVID-19) 危機分析

  • COVID-19:當前的統計數據和未來的預期影響
  • 當前 GDP 預測和預期影響
  • COVID-19 和影響分析
    • 市場收入:按產品類型
    • 市場收入:按銷售渠道
    • 市場收入:按處方計算
    • 市場收入:按國家/地區

第 7 章全球乾眼症市場:需求分析和預測(基於數量)

  • 過去的市場和分析(以數量為基礎)
  • 當前和未來的市場和預測(以數量為基礎)
    • 同比增長率(YoY)趨勢分析

第 8 章全球乾眼症市場:價格分析

  • 按地區劃分的價格分析:按產品分類

第 9 章全球乾眼症市場:需求分析和預測

  • 過去的市場和分析
  • 當前和未來的市場和預測
    • 同比增長率(YoY)趨勢分析

第 10 章全球乾眼症市場分析與預測:按產品類型

  • 簡介/主要發現
  • 過去的市場:按產品類型
  • 當前和未來的市場分析和預測:按產品類型
    • 環孢素
    • 外用皮質類固醇
    • 人工淚液
    • 淚點塞
    • 歐米茄補充劑
    • 其他
  • 市場向心力分析:按產品類型

全球乾眼症市場的第 11 章分析和預測:按處方

  • 簡介/主要發現
  • 過去的市場:按處方
  • 當前和未來的市場分析和預測:按處方
    • 處方
    • 場外交易
    • 醫療設備
  • 市場向心力分析:按處方

第 12 章全球乾眼症市場分析與預測:按銷售渠道

  • 簡介/主要發現
  • 過去的市場:按銷售渠道
  • 當前和未來的市場分析和預測:按銷售渠道
    • 醫院藥房
    • 眼科診所
    • 零售藥店
    • 網上藥店
  • 市場向心力分析:按分銷渠道

第 13 章全球乾眼症市場分析與預測:按地區

  • 簡介
  • 過去按地區劃分的市場規則
  • 當前和未來的市場分析和預測:按地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東/非洲 (MEA)
  • 市場向心力分析:按地區

第14章北美乾眼症市場分析與預測

  • 簡介
  • 過去的市場:按市場類別
  • 當前/未來市場分析和預測:按市場類別
    • 按國家/地區
    • 按產品類型
    • 憑處方
    • 按分銷渠道
  • 市場向心力分析
  • 市場推動者:影響分析

第15章拉丁美洲乾眼症市場分析與預測

第16章歐洲乾眼症市場分析與預測

第17章南亞乾眼症市場分析與預測

第18章東亞乾眼症市場分析與預測

第19章大洋洲乾眼症市場分析與預測

第20章中東/非洲乾眼症市場分析與預測

第21章主要國家乾眼症市場分析與預測

  • 美國市場
    • 按產品類型
    • 憑處方
    • 按分銷渠道
  • 加拿大市場
  • 巴西市場
  • 墨西哥市場
  • 英國市場
  • 德國市場
  • 法國市場
  • 意大利市場
  • 西班牙市場
  • 俄羅斯市場
  • 波蘭市場
  • 日本市場
  • 中國市場
  • 韓國市場
  • 印度市場
  • 泰國市場
  • 印尼市場
  • 馬來西亞市場
  • 越南市場
  • 澳大利亞市場
  • 新西蘭市場
  • 海灣合作委員會 (GCC) 國家市場
  • 南非市場

第22章市場結構分析

  • 市場分析:按公司層級
  • 市場集中度

第23章競爭分析

  • 競爭儀表板
  • 比賽詳情
    • Allergan Plc.
    • Novartis AG
    • Otsuka Pharmaceutical Co.,Ltd.
    • Santen Pharmaceutical Co Ltd.
    • Bausch Health Companies Inc.
    • Akorn, Inc.
    • Johnson & Johnson, Inc.
    • Thea Pharmaceuticals Limited
    • OASIS Medical
    • Altaire Pharmaceuticals Inc.
    • Boiron USA
    • Similasan Corporation
    • Scope Ophthalmics Ltd.
    • Reckitt Benckiser Group PLC
    • Medicom Healthcare Ltd
    • FDC Limited.
    • Lupin Limited
    • Jamjoom Pharmaceuticals Co.
    • Sentiss Pharma Private limited

第 24 章本報告的先決條件和首字母縮略詞

第25章分析方法

目錄
Product Code: PMRREP32300

Dry Eye Syndrome Treatment Market - Scope of Report

A latest publication by Persistence Market Research on the global dry eye syndrome treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The report offers a detailed study of the market background, which includes macroeconomic factors, forecast factors, drivers, restraints, trends, and opportunities in the market. The principal aim of the study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for successful growth in the dry eye syndrome treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for dry eye syndrome treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the dry eye syndrome treatment market. Insights and wisdom presented in this study can be leveraged by shareholders, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the dry eye syndrome treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, under the data submitted in this market report, minor companies and new entrants in the dry eye syndrome treatment industry can be aided in making suitable company choices to achieve traction in market.

Key Market Segments

Persistence Market Research's study on the dry eye syndrome treatment market offers information divided into four important segments- product, prescription, distribution channel, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Product

Cyclosporine

Topical Corticosteroids

Artificial Tears

Punctal Plugs

Removable

Dissolvable

Omega Supplements

Others

Prescription

Rx

OTC

Medical Device

Distribution Channel

Hospital Pharmacies

Eye Health Clinics

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

South Asia

Key Questions Answered in Report

Which regions will continue to remain the most profitable regional markets for dry eye syndrome treatment?

Which factors will induce a change in the demand for dry eye syndrome treatment during the assessment period?

How will changing trends impact the market?

How can market players capture the low-hanging opportunities in developed regions?

What are the winning strategies of stakeholders in the dry eye syndrome treatment market to upscale their position in this landscape?

What are the restraints that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends in ophthalmic sectors that will impact the market?

How can businesses avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the dry eye syndrome treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the dry eye syndrome treatment market, and makes Persistence Market Research's projections on the growth prospects of the market more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Method Innovation / Development Trends

4. Key Success Factors

  • 4.1. Dry Eye Syndrome Epidemiology, By Country, 2015-2030
    • 4.1.1. Prevalence of dry eye disease
    • 4.1.2. Potential patient number of dry eye disease
    • 4.1.3. Percentage of severity, mild, modulate, and severe
    • 4.1.4. Patients number under treatment
    • 4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient
  • 4.2. Regulatory Scenario
  • 4.3. New Product Launches
  • 4.4. Reimbursement Scenario
  • 4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries
  • 4.6. Dry Eye Syndrome - Patient Treatment Journey

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Industry Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increase in Geriatric Population
    • 5.2.2. Increasing Prevalence of Dry Eye Syndrome
    • 5.2.3. Limited Awareness About Dry Eye Syndrome
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Trends
    • 5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. Current COVID19 Statistics and Probable Future Impact
  • 6.2. Current GDP Projection and Probable Impact
  • 6.3. COVID19 and Impact Analysis
    • 6.3.1. Revenue By Product Type
    • 6.3.2. Revenue By Distribution Channel
    • 6.3.3. By Prescription Type
    • 6.3.4. Revenue By Country

7. Global Dry Eye Syndrome Market Demand (In Volume Units) Analysis 2015-2019 and Forecast, 2020-2030

  • 7.1. Historical Market (Volume) Analysis, 2015-2019
  • 7.2. Current and Future Market (Volume) Projections, 2020-2030
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Dry Eye Syndrome Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product

9. Global Dry Eye Syndrome Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030, By Product Type

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
    • 10.3.1. Cyclosporin
    • 10.3.2. Topical Corticosteroids
    • 10.3.3. Artificial Tears
    • 10.3.4. Punctal plugs
      • 10.3.4.1. Removable
      • 10.3.4.2. Dissolvable
    • 10.3.5. Omega Supplements
    • 10.3.6. Others
  • 10.4. Others Market Attractiveness Analysis By Product Type

11. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) By Prescription Type, 2015-2019
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Prescription Type, 2020-2030
    • 11.3.1. Rx
    • 11.3.2. OTC
    • 11.3.3. Medical Device
  • 11.4. Others Market Attractiveness Analysis By Prescription Type

12. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) By Distribution Channel, 2015-2019
  • 12.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2020-2030
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Eye Health Clinics
    • 12.3.3. Retail Pharmacies
    • 12.3.4. Online Pharmacies
  • 12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product Type
    • 14.3.3. By Prescription Type
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. Latin America Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019
  • 15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Rest of Latin America
    • 15.3.2. By Product Type
    • 15.3.3. By Prescription Type
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. Europe Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. Poland
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product Type
    • 16.3.3. By Prescription Type
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. South Asia Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2020-2030
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Vietnam
      • 17.3.1.6. Rest of South Asia
    • 17.3.2. By Product Type
    • 17.3.3. By Prescription Type
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. East Asia Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product Type
    • 18.3.3. By Prescription Type
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Oceania Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2015-2019
  • 19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product Type
    • 19.3.3. By Prescription Type
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
  • 19.5. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
  • 20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020-2030
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. South Africa
      • 20.3.1.3. North Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Prescription Type
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
  • 20.5. Drivers and Restraints - Impact Analysis

21. Key Countries Dry Eye Syndrome Market Analysis 2015-2019 and Forecast 2020-2030

  • 21.1. U.S. Dry Eye Syndrome Market Analysis
    • 21.1.1. By Product Type
    • 21.1.2. By Prescription Type
    • 21.1.3. By Distribution Channel
  • 21.2. Canada Dry Eye Syndrome Market Analysis
    • 21.2.1. By Product Type
    • 21.2.2. By Prescription Type
    • 21.2.3. By Distribution Channel
  • 21.3. Brazil Dry Eye Syndrome Market Analysis
    • 21.3.1. By Product Type
    • 21.3.2. By Prescription Type
    • 21.3.3. By Distribution Channel
  • 21.4. Mexico Dry Eye Syndrome Market Analysis
    • 21.4.1. By Product Type
    • 21.4.2. By Prescription Type
    • 21.4.3. By Distribution Channel
  • 21.5. U.K. Dry Eye Syndrome Market Analysis
    • 21.5.1. By Product Type
    • 21.5.2. By Prescription Type
    • 21.5.3. By Distribution Channel
  • 21.6. Germany Dry Eye Syndrome Market Analysis
    • 21.6.1. By Product Type
    • 21.6.2. By Prescription Type
    • 21.6.3. By Distribution Channel
  • 21.7. France Dry Eye Syndrome Market Analysis
    • 21.7.1. By Product Type
    • 21.7.2. By Prescription Type
    • 21.7.3. By Distribution Channel
  • 21.8. Italy Dry Eye Syndrome Market Analysis
    • 21.8.1. By Product Type
    • 21.8.2. By Prescription Type
    • 21.8.3. By Distribution Channel
  • 21.9. Spain Dry Eye Syndrome Market Analysis
    • 21.9.1. By Product Type
    • 21.9.2. By Prescription Type
    • 21.9.3. By Distribution Channel
  • 21.10. Russia Dry Eye Syndrome Market Analysis
    • 21.10.1. By Product Type
    • 21.10.2. By Prescription Type
    • 21.10.3. By Distribution Channel
  • 21.11. Poland Dry Eye Syndrome Market Analysis
    • 21.11.1. By Product Type
    • 21.11.2. By Prescription Type
    • 21.11.3. By Distribution Channel
  • 21.12. Japan Dry Eye Syndrome Market Analysis
    • 21.12.1. By Product Type
    • 21.12.2. By Prescription Type
    • 21.12.3. By Distribution Channel
  • 21.13. China Dry Eye Syndrome Market Analysis
    • 21.13.1. By Product Type
    • 21.13.2. By Prescription Type
    • 21.13.3. By Distribution Channel
  • 21.14. South Korea Dry Eye Syndrome Market Analysis
    • 21.14.1. By Product Type
    • 21.14.2. By Prescription Type
    • 21.14.3. By Distribution Channel
  • 21.15. India Dry Eye Syndrome Market Analysis
    • 21.15.1. By Product Type
    • 21.15.2. By Prescription Type
    • 21.15.3. By Distribution Channel
  • 21.16. Thailand Dry Eye Syndrome Market Analysis
    • 21.16.1. By Product Type
    • 21.16.2. By Prescription Type
    • 21.16.3. By Distribution Channel
  • 21.17. Indonesia Dry Eye Syndrome Market Analysis
    • 21.17.1. By Product Type
    • 21.17.2. By Prescription Type
    • 21.17.3. By Distribution Channel
  • 21.18. Malaysia Dry Eye Syndrome Market Analysis
    • 21.18.1. By Product Type
    • 21.18.2. By Prescription Type
    • 21.18.3. By Distribution Channel
  • 21.19. Vietnam Dry Eye Syndrome Market Analysis
    • 21.19.1. By Product Type
    • 21.19.2. By Prescription Type
    • 21.19.3. By Distribution Channel
  • 21.20. Australia Dry Eye Syndrome Market Analysis
    • 21.20.1. By Product Type
    • 21.20.2. By Prescription Type
    • 21.20.3. By Distribution Channel
  • 21.21. New Zealand Dry Eye Syndrome Market Analysis
    • 21.21.1. By Product Type
    • 21.21.2. By Prescription Type
    • 21.21.3. By Distribution Channel
  • 21.22. GCC Countries Dry Eye Syndrome Market Analysis
    • 21.22.1. By Product Type
    • 21.22.2. By Prescription Type
    • 21.22.3. By Distribution Channel
  • 21.23. South Africa Dry Eye Syndrome Market Analysis
    • 21.23.1. By Product Type
    • 21.23.2. By Prescription Type
    • 21.23.3. By Distribution Channel

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Concentration

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Deep Dive
    • 23.2.1. Allergan Plc.
      • 23.2.1.1. Product Portfolio
      • 23.2.1.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.1.3. Sales Footprint
      • 23.2.1.4. Strategy Overview
        • 23.2.1.4.1. Marketing Strategy
        • 23.2.1.4.2. Product Strategy
        • 23.2.1.4.3. Channel Strategy
    • 23.2.2. Novartis AG
      • 23.2.2.1. Product Portfolio
      • 23.2.2.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.2.3. Sales Footprint
      • 23.2.2.4. Strategy Overview
        • 23.2.2.4.1. Marketing Strategy
        • 23.2.2.4.2. Product Strategy
        • 23.2.2.4.3. Channel Strategy
    • 23.2.3. Otsuka Pharmaceutical Co.,Ltd.
      • 23.2.3.1. Product Portfolio
      • 23.2.3.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.3.3. Sales Footprint
      • 23.2.3.4. Strategy Overview
        • 23.2.3.4.1. Marketing Strategy
        • 23.2.3.4.2. Product Strategy
        • 23.2.3.4.3. Channel Strategy
    • 23.2.4. Santen Pharmaceutical Co Ltd.
      • 23.2.4.1. Product Portfolio
      • 23.2.4.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.4.3. Sales Footprint
      • 23.2.4.4. Strategy Overview
        • 23.2.4.4.1. Marketing Strategy
        • 23.2.4.4.2. Product Strategy
        • 23.2.4.4.3. Channel Strategy
    • 23.2.5. Bausch Health Companies Inc.
      • 23.2.5.1. Product Portfolio
      • 23.2.5.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.5.3. Sales Footprint
      • 23.2.5.4. Strategy Overview
        • 23.2.5.4.1. Marketing Strategy
        • 23.2.5.4.2. Product Strategy
        • 23.2.5.4.3. Channel Strategy
    • 23.2.6. Akorn, Inc.
      • 23.2.6.1. Product Portfolio
      • 23.2.6.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.6.3. Sales Footprint
      • 23.2.6.4. Strategy Overview
        • 23.2.6.4.1. Marketing Strategy
        • 23.2.6.4.2. Product Strategy
        • 23.2.6.4.3. Channel Strategy
    • 23.2.7. Johnson & Johnson, Inc.
      • 23.2.7.1. Product Portfolio
      • 23.2.7.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.7.3. Sales Footprint
      • 23.2.7.4. Strategy Overview
        • 23.2.7.4.1. Marketing Strategy
        • 23.2.7.4.2. Product Strategy
        • 23.2.7.4.3. Channel Strategy
    • 23.2.8. Thea Pharmaceuticals Limited
      • 23.2.8.1. Product Portfolio
      • 23.2.8.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.8.3. Sales Footprint
      • 23.2.8.4. Strategy Overview
        • 23.2.8.4.1. Marketing Strategy
        • 23.2.8.4.2. Product Strategy
        • 23.2.8.4.3. Channel Strategy
    • 23.2.9. OASIS Medical
      • 23.2.9.1. Product Portfolio
      • 23.2.9.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.9.3. Sales Footprint
      • 23.2.9.4. Strategy Overview
        • 23.2.9.4.1. Marketing Strategy
        • 23.2.9.4.2. Product Strategy
        • 23.2.9.4.3. Channel Strategy
    • 23.2.10. Altaire Pharmaceuticals Inc.
      • 23.2.10.1. Product Portfolio
      • 23.2.10.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.10.3. Sales Footprint
      • 23.2.10.4. Strategy Overview
        • 23.2.10.4.1. Marketing Strategy
        • 23.2.10.4.2. Product Strategy
        • 23.2.10.4.3. Channel Strategy
    • 23.2.11. Boiron USA
      • 23.2.11.1. Product Portfolio
      • 23.2.11.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.11.3. Sales Footprint
      • 23.2.11.4. Strategy Overview
        • 23.2.11.4.1. Marketing Strategy
        • 23.2.11.4.2. Product Strategy
        • 23.2.11.4.3. Channel Strategy
    • 23.2.12. Similasan Corporation
      • 23.2.12.1. Product Portfolio
      • 23.2.12.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.12.3. Sales Footprint
      • 23.2.12.4. Strategy Overview
        • 23.2.12.4.1. Marketing Strategy
        • 23.2.12.4.2. Product Strategy
        • 23.2.12.4.3. Channel Strategy
    • 23.2.13. Scope Ophthalmics Ltd.
      • 23.2.13.1. Product Portfolio
      • 23.2.13.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.13.3. Sales Footprint
      • 23.2.13.4. Strategy Overview
        • 23.2.13.4.1. Marketing Strategy
        • 23.2.13.4.2. Product Strategy
        • 23.2.13.4.3. Channel Strategy
    • 23.2.14. Reckitt Benckiser Group PLC
      • 23.2.14.1. Product Portfolio
      • 23.2.14.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.14.3. Sales Footprint
      • 23.2.14.4. Strategy Overview
        • 23.2.14.4.1. Marketing Strategy
        • 23.2.14.4.2. Product Strategy
        • 23.2.14.4.3. Channel Strategy
    • 23.2.15. Medicom Healthcare Ltd
      • 23.2.15.1. Product Portfolio
      • 23.2.15.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.15.3. Sales Footprint
      • 23.2.15.4. Strategy Overview
        • 23.2.15.4.1. Marketing Strategy
        • 23.2.15.4.2. Product Strategy
        • 23.2.15.4.3. Channel Strategy
    • 23.2.16. FDC Limited.
      • 23.2.16.1. Product Portfolio
      • 23.2.16.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.16.3. Sales Footprint
      • 23.2.16.4. Strategy Overview
        • 23.2.16.4.1. Marketing Strategy
        • 23.2.16.4.2. Product Strategy
        • 23.2.16.4.3. Channel Strategy
    • 23.2.17. Lupin Limited
      • 23.2.17.1. Product Portfolio
      • 23.2.17.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.17.3. Sales Footprint
      • 23.2.17.4. Strategy Overview
        • 23.2.17.4.1. Marketing Strategy
        • 23.2.17.4.2. Product Strategy
        • 23.2.17.4.3. Channel Strategy
    • 23.2.18. Jamjoom Pharmaceuticals Co.
      • 23.2.18.1. Product Portfolio
      • 23.2.18.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.18.3. Sales Footprint
      • 23.2.18.4. Strategy Overview
        • 23.2.18.4.1. Marketing Strategy
        • 23.2.18.4.2. Product Strategy
        • 23.2.18.4.3. Channel Strategy
    • 23.2.19. Sentiss Pharma Private limited
      • 23.2.19.1. Product Portfolio
      • 23.2.19.2. Profitability by Market Segments (Drugs/Channel/Region)
      • 23.2.19.3. Sales Footprint
      • 23.2.19.4. Strategy Overview
        • 23.2.19.4.1. Marketing Strategy
        • 23.2.19.4.2. Product Strategy
        • 23.2.19.4.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

  • Table 01: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 02: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 03: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 04: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 05: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 06: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 07: North America Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 08: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 09: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 10: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 11: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 12: Latin America Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 13: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 14: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 15: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 16: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 17: Europe Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 18: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 19: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 20: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 21: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 22: South Asia Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 23: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 24: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 25: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 26: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 27: East Asia Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 28: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 29: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 30: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 31: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 32: Oceania Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 33: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 34: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 35: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 36: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 37: MEA Dry Eye Syndrome Treatment Volume (000' Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 38: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type
  • Table 39: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

List of Figures

  • Figure 01: Global Dry Eye Syndrome Treatment Market Volume Analysis (000' Units), 2015-2019
  • Figure 02: Dry Eye Syndrome Treatment Market Volume Forecast (000' Units), 2020-2030
  • Figure 03: Cyclosporine Pricing Analysis (US$) for Per Unit (Per pack of 60 0.4 ml vials), By Region, 2019
  • Figure 04: Topical Corticosteroids Pricing Analysis (US$) for Per Unit (Per 5ml bottle), By Region, 2019
  • Figure 05: Artificial Tears Pricing Analysis (US$) for Per Unit (Per pack of 15 ml), By Region, 2019
  • Figure 06: Removable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2019
  • Figure 07: Dissolvable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2019
  • Figure 08: Oral Omega Supplements Corticosteroids Pricing Analysis (US$) for Per Unit (Per pack of 120 capsules), By Region, 2019
  • Figure 09: Global Dry Eye Syndrome Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
  • Figure 10: Global Dry Eye Syndrome Treatment Market Value (US$ Mn), 2015-2019
  • Figure 11: Global Dry Eye Syndrome Treatment Market Absolute $ Opportunity (US$ Mn), 2019-2030
  • Figure 12: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Product Type, 2020 & 2030
  • Figure 13: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Product Type, 2019-2030
  • Figure 14: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Product Type, 2020-2030
  • Figure 15: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Prescription Type, 2020 & 2030
  • Figure 16: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Prescription Type, 2019-2030
  • Figure 17: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Prescription Type, 2020-2030
  • Figure 18: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2020 & 2030
  • Figure 19: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2019-2030
  • Figure 20: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2020-2030
  • Figure 21: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 22: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Region, 2019-2030
  • Figure 23: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Region, 2020-2030
  • Figure 24: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 25: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 26: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 27: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 28: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 29: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 30: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 31: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 32: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 33: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 34: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 35: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 36: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 37: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 38: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 39: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 40: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 41: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 42: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 43: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 44: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 45: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 46: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 47: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 48: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 49: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 50: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 51: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 52: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 53: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 54: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 55: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 56: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 57: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 58: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 59: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 60: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019
  • Figure 61: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030
  • Figure 62: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type
  • Figure 63: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type
  • Figure 64: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 65: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country
  • Figure 66: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 67: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 68: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 69: U.S. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 70: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 71: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 72: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 73: Canada Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 74: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 75: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 76: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 77: Brazil Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 78: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 79: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 80: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 81: Mexico Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 82: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 83: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 84: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 85: U.K. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 86: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 87: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 88: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 89: Germany Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 90: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 91: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 92: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 93: France Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 94: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 95: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 96: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 97: Italy Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 98: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 99: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 100: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 101: Spain Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 102: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 103: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 104: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 105: Russia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 106: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 107: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 108: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 109: Poland Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 110: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 111: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 112: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 113: Japan Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 114: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 115: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 116: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 117: China Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 118: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 119: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 120: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 121: South Korea Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 122: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 123: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 124: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 125: India Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 126: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 127: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 128: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 129: Thailand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 130: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 131: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 132: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 133: Indonesia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 134: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 135: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 136: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 137: Malaysia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 138: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 139: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 140: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 141: Vietnam Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 142: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 143: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 144: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 145: Australia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 146: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 147: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 148: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 149: New Zealand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 150: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 151: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 152: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 153: GCC Countries Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030
  • Figure 154: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030
  • Figure 155: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030
  • Figure 156: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030
  • Figure 157: South Africa Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030